OraSure Technologies, Inc. (NASDAQ:OSUR) will be discussing 3Q20 financial results with the investment community.on 4th November 2020 at 12:00 PM eastern time.
Those interested in listening to the conference call live via the Internet can visit www.orasure.com
Earnings Expectation
OraSure Technologies, Inc. is reporting third quarter financial results on Wednesday 4th November 2020, after market close.
According to analysts surveyed by Thomson Reuters, OSUR is expected to report 3Q20 loss of $ 0.07 per share from revenue of $ 41.70 million.
For the full year, analysts anticipate top line of $ 165.29 million, while looking forward to loss of $ 0.26 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 145.00 million ~ $ 155.00 million, where as bottomline are predicted in a range of $ -0.10 ~ $ -0.07 per share
Click Here For More Historical Outlooks Of OraSure Technologies, Inc.
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, OSUR and DNAG. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests.
